Article
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.
Respiratory research - 29 Oct 2013
Beeh Kai M, Glaab Thomas, Stowasser Susanne, Schmidt Hendrik, Fabbri Leonardo M, Rabe Klaus F, Vogelmeier Claus F
Abstract excerpt
BACKGROUND: Data examining the characteristics of patients with frequent exacerbations of chronic obstructive pulmonary disease (COPD) and associated hospitalisations and mortality are scarce. METHODS: Post-hoc analysis of the Prevention Of Exacerbations with Tiotropium in COPD (POET-COPD) trial, targeting exacerbations as the primary endpoint. Patients were classified as non-, infrequent, and frequent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.